DaxibotulinumtoxinA for Injection for the Management of Plantar Fasciitis

NCT02973269 PHASE2 TERMINATED Results posted

The specific aim of the study is to compare the safety and efficacy of a single administration of DaxibotulinumtoxinA for Injection versus placebo for managing plantar fasciitis.

Details

Lead sponsor	Revance Therapeutics, Inc.
Phase	PHASE2
Status	TERMINATED
Enrolment	7
Start date	Mon Nov 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Wed May 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Plantar Fasciitis

Interventions

• daxibotulinumtoxin type A
• Placebo

Countries

United States